Category: Specific Treatments
Specific Treatments
5-ASA
Mesalamine
Steroids
Budesonide
Infliximab
Remicade
Adalimumab
Humira
Thiopurines
Imuran, 6-MP
Vedolizumab
Entyvio
Ustekinumab
Stelara
Tofacitinib
Xeljanz
Email Newsletter
Over 1,200 subscribers!
Recent News
FMT safe, well tolerated for recurrent CDI in IBD
Atopic disease linked with increased risk for IBD
Low risk for CRC with dysplasia rection in IBD patients
Home Remicade infusions linked with suboptimal outcomes in IBD
Low incidence of SARs-CoV-2 among IBD patients on biologic therapy
‘This is the world without one vaccine:’ Addressing vaccine-hesitancy in IBD
Emerging therapies for IBD: Finding long-term treatment without steroids
Smarter, earlier, deeper: Choosing an initial IBD therapy
Childhood-onset IBD leads to shorter adult height
Adalimumab trials show low rate of IBD adverse events